BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Proteon Therapeutics, Inc. 

4420 Madison Avenue
Suite 180
Kansas City  Missouri  64111  U.S.A.
Phone: 816-531-0028 Fax: 816-531-3079


SEARCH JOBS


Industry
Biotechnology






 Company News
Proteon Therapeutics, Inc., Looking Past Ill-Fated Novartis AG (NVS) Deal, Goes It Alone 3/18/2014 7:33:36 AM    More...
Proteon Therapeutics, Inc. Announces Orphan Drug Designation In The European Union For PRT-201 1/8/2014 10:20:52 AM    More...
Proteon Therapeutics, Inc. Announces Positive Phase 2 Trial Results of PRT-201 in Chronic Kidney Disease Patients Undergoing Surgical Placement of an Arteriovenous Fistula for Hemodialysis 1/4/2013 9:52:43 AM    More...
Awaiting Novartis AG Acquisition, Biotech Firm Proteon Therapeutics, Inc. Raises $15.2 Million 8/12/2011 8:04:43 AM    More...
Proteon Therapeutics, Inc. Initiates Patient Enrollment in Phase 2 Clinical Study of PRT-201 in Hemodialysis Patients 4/14/2011 12:38:48 PM    More...
Proteon Therapeutics, Inc. Named 2010 Technology Pioneer by the World Economic Forum 12/3/2009 9:08:16 AM    More...
Proteon Therapeutics, Inc. Completes Second Closing of Equity Financing; Raises Total Series B to $50 Million 5/28/2009 7:27:50 AM    More...
Proteon Therapeutics, Inc. Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement to Sell for $550 Million 3/5/2009 7:21:58 AM    More...
Proteon Therapeutics, Inc. Presents New Data on PRT-201 at the Annual Meeting of the American Society of Nephrology in Philadelphia 11/6/2008 9:38:10 AM    More...
Proteon Therapeutics, Inc. to Present New Data on PRT-201 at Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium in Washington, D.C., October 13, 2008 10/13/2008 11:30:52 AM    More...
12

//-->